American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improvement in individual symptoms and total symptom score (TSS) and matching-adjusted indirect comparison (MAIC) analysis to compare TSS as a continuous endpoint in patients with myelofibrosis treated with pelabresib in combination with ruxolitinib versus janus kinase inhibitor monotherapy
    Meeting Abstract

    Mesa, R.; Kremyanskaya, M.; Patriarca, A.; Gupta, V.; Palandri, F.; Devos, T.; Harrison, C.; Rampal, R. K.; Talpaz, M.; Vannucchi, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of polymorphisms in pharmacokinetic genes on tyrosine kinase inhibitor (TKI) tolerability in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
    Meeting Abstract

    Patel, J. N.; Lopes, K. E.; Druhan, L. J.; Zeng, H.; Beam, T.; Moore, D. C.; Salem, A.; Hamadeh, I.; Savage, Q.; Chojecki, A. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation in patients with relapsed or refractory acute leukemia
    Meeting Abstract

    Elias, S.; Walji, M.; Brown, S.; Devlin, S. M.; Papadopoulos, E. B.; Jakubowski, A. A.; Ponce, D. M.; Young, J. W.; Giralt, S. A.; Perales, M. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient and the value of addressing the unmet need
    Meeting Abstract

    Maziarz, R. T.; Devine, S. M.; Garrison, L. P.; Agodoa, I.; Badaracco, J.; Gitlin, M.; Perales, M. A.
    Blood (2022)

    Fulltext@MSK | Save
  • Indirect comparisons of the efficacy of subcutaneous epcoritamab vs chemoimmunotherapy in patients with relapsed or refractory large B-cell lymphoma
    Meeting Abstract

    Salles, G.; Wang, A.; Mutebi, A.; Alshreef, A.; Davies, K. R.; van de Wetering, G.; Chirikov, V.
    Blood (2022)

    Fulltext@MSK | Save
  • Cytokine release syndrome (CRS) is not required for CAR-T cell efficacy in aggressive large B-NHL
    Meeting Abstract

    Bhaskar, S.; Patel, V.; Porter, D. L.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Tomas, A. A.; Bishop, M. R.; McGuirk, J. P.; Maziarz, R. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Factors associated with early mortality in patients with multiple myeloma: A SEER analysis
    Meeting Abstract

    Wei, J. X.; Sisto, A.; Shastri, A.; Sica, R. A.; Mantzaris, I.; Kornblum, N.; Shah, U. A.; Janakiram, M.; Gritsman, K.; Verma, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • PLX-R18 (avoplacel), a placental expanded mesenchymal-like stromal cell therapy shows favorable safety and appears to improve incomplete hematopoietic recovery after hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Lazarus, H. M.; McGuirk, J. P.; Zuckerman, T.; Metheny, L.; Pineiro, L.; Litzow, M. R.; Rowley, S. D.; Avni, B.; Tamari, R.; Sheleg, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Ponce, D. M.; Peled, J. U.; Tejura, B.; Ford, C.; van den Brink, M. R. M.; Lombardo, M. J.; Kosuri, S.; Khera, N.; Defilipp, Z.; von Moltke, L.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 3 double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of AB-205 plus standard of care (SOC) versus placebo plus standard of care in adults with lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (E-CELERATE) (NCT05181540) - Trials in progress
    Meeting Abstract

    Scordo, M.; Shouse, G.; Mountjoy, L.; Gauthier, J.; Dholaria, B.; Rowley, S. D.; Pantin, J. M.; Defilipp, Z.; Mead, M.; Finnegan, P.
    Blood (2022)

    Fulltext@MSK | Save